European Stroke Prevention Study "ESPS-2"

Completed

Phase N/A Results

Summary of Purpose

To study the effectiveness of dipyridamole and low-dose aspirin, taken alone or in combination, for secondary stroke prevention.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 November 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Boehringer-Ingelheim

Trial Design

Randomized, double-blind, placebo-controlled, trial of 6602 patients at 59 centers.

Contacts

  • Jan Van Rijswijcklaan 106, B-2018 Antwerp, Belgium.

    h.diener@uni-essen.de